These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 20378575

  • 1. Splenic marginal zone lymphoma: hydra with many heads?
    Arcaini L, Paulli M.
    Haematologica; 2010 Apr; 95(4):534-7. PubMed ID: 20378575
    [No Abstract] [Full Text] [Related]

  • 2. CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases.
    Baseggio L, Traverse-Glehen A, Petinataud F, Callet-Bauchu E, Berger F, Ffrench M, Couris CM, Thieblemont C, Morel D, Coiffier B, Salles G, Felman P.
    Haematologica; 2010 Apr; 95(4):604-12. PubMed ID: 20015887
    [Abstract] [Full Text] [Related]

  • 3. Characteristics of CD5-positive splenic marginal zone lymphoma with leukemic manifestation ; clinical, flow cytometry, and histopathological findings of 11 cases.
    Kojima M, Sato E, Oshimi K, Murase T, Koike T, Tsunoda S, Matsumoto T, Marutsuka K, Ogiya D, Moriuchi M, Tokunaka M, Yara Kikuti Y, Kikuchi T, Nakamura N, Ando K.
    J Clin Exp Hematop; 2010 Apr; 50(2):107-12. PubMed ID: 21123968
    [Abstract] [Full Text] [Related]

  • 4. Clinical and biological features of B-cell neoplasms with CDK6 translocations: an association with a subgroup of splenic marginal zone lymphomas displaying frequent CD5 expression, prolymphocytic cells, and TP53 abnormalities.
    Gailllard B, Cornillet-Lefebvre P, Le QH, Maloum K, Pannetier M, Lecoq-Lafon C, Grange B, Jondreville L, Michaux L, Nadal N, Ittel A, Luquet I, Struski S, Lefebvre C, Gaillard JB, Lafage-Pochitaloff M, Balducci E, Penther D, Barin C, Collonge-Rame MA, Jimenez-Poquet M, Richebourg S, Lemaire P, Defasque S, Radford-Weiss I, Bidet A, Susin SA, Nguyen-Khac F, Chapiro E, Groupe Francophone de Cytogénétique Hématologique.
    Br J Haematol; 2021 Apr; 193(1):72-82. PubMed ID: 33314017
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA expression profile in splenic marginal zone lymphoma.
    Bouteloup M, Verney A, Rachinel N, Callet-Bauchu E, Ffrench M, Coiffier B, Magaud JP, Berger F, Salles GA, Traverse-Glehen A.
    Br J Haematol; 2012 Jan; 156(2):279-81. PubMed ID: 21902683
    [No Abstract] [Full Text] [Related]

  • 6. Clinicopathological features of CD5-positive splenic marginal zone lymphoma.
    Li Y, Wang G, Liu E, Zhang D, Zhang Y, Jian X, Zhao W, Li W.
    J Clin Pathol; 2024 May 17; 77(6):421-425. PubMed ID: 36922019
    [Abstract] [Full Text] [Related]

  • 7. Splenic marginal zone lymphoma.
    Piris MA, Onaindía A, Mollejo M.
    Best Pract Res Clin Haematol; 2017 May 17; 30(1-2):56-64. PubMed ID: 28288718
    [Abstract] [Full Text] [Related]

  • 8. [Clinicopathologic features and differential diagnosis of splenic B-cell marginal zone lymphoma involving bone marrow].
    Sun Q, Zhang PH, Liu EB, Liu W, Li ZQ, Yang QY, Fang LH, Sun FJ, Chen HS, Qiu LG.
    Zhonghua Bing Li Xue Za Zhi; 2013 Apr 17; 42(4):234-8. PubMed ID: 23928529
    [Abstract] [Full Text] [Related]

  • 9. Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation.
    Hoehn D, Miranda RN, Kanagal-Shamanna R, Lin P, Medeiros LJ.
    Hum Pathol; 2012 Nov 17; 43(11):1828-38. PubMed ID: 22520947
    [Abstract] [Full Text] [Related]

  • 10. CD5+ extranodal marginal zone B-cell (MALT) lymphoma.
    Wright DH.
    Am J Clin Pathol; 1996 Sep 17; 106(3):438. PubMed ID: 8816603
    [No Abstract] [Full Text] [Related]

  • 11. [Clinicopathologic study of splenic marginal zone B-cell lymphoma].
    Zhang YN, Zheng YY, Zhou XG, Zhang SH, Jin Y, Xie JL, Chen SY, Shi Y, Wu LH.
    Zhonghua Bing Li Xue Za Zhi; 2009 Apr 17; 38(4):243-7. PubMed ID: 19575895
    [Abstract] [Full Text] [Related]

  • 12. Composite splenic marginal zone lymphoma and classic Hodgkin lymphoma -- an unusual combination.
    Elmahy H, Hawley I, Beard J.
    Int J Lab Hematol; 2007 Dec 17; 29(6):461-3. PubMed ID: 17988302
    [Abstract] [Full Text] [Related]

  • 13. [Splenic lymphoma, diagnosis and treatment].
    Riller Q, Cohen-Aubart F, Roos-Weil D.
    Rev Med Interne; 2022 Oct 17; 43(10):608-616. PubMed ID: 35691756
    [Abstract] [Full Text] [Related]

  • 14. Immunohistochemical Expression of Lymphoid Enhancer Binding Factor 1 in CD5-Positive Marginal Zone, Lymphoplasmacytic, and Follicular Lymphomas.
    Patel N, Durkin L, Bodo J, Hsi ED.
    Am J Clin Pathol; 2020 Apr 15; 153(5):646-655. PubMed ID: 31953940
    [Abstract] [Full Text] [Related]

  • 15. Validation of the simplified prognostic score for splenic marginal zone lymphoma of the Splenic Marginal Zone Lymphoma Working Group.
    Kalpadakis C, Pangalis GA, Angelopoulou MK, Sachanas S, Kontopidou F, Moschogiannis M, Ximeri M, Tsirkinidis P, Yiakoumis X, Papadaki HA, Vassilakopoulos TP.
    Leuk Lymphoma; 2014 Nov 15; 55(11):2640-2. PubMed ID: 24576167
    [No Abstract] [Full Text] [Related]

  • 16. [Splenic pathology. Case no 2. Splenic marginal zone B-cell lymphoma].
    Traverse-Glehen A, Berger F.
    Ann Pathol; 2010 Jun 15; 30(3):206-10. PubMed ID: 20621598
    [No Abstract] [Full Text] [Related]

  • 17. Higher expression levels of activation-induced cytidine deaminase distinguish hairy cell leukemia from hairy cell leukemia-variant and splenic marginal zone lymphoma.
    Hockley SL, Morilla A, Else M, Dearden C, Catovsky D, Morgan GJ, Matutes E, Gonzalez D.
    Leukemia; 2010 May 15; 24(5):1084-6. PubMed ID: 20237507
    [No Abstract] [Full Text] [Related]

  • 18. Splenic marginal zone B-cell lymphoma: a distinct clinicopathological and molecular entity. Recent advances in ontogeny and classification.
    Traverse-Glehen A, Baseggio L, Salles G, Felman P, Berger F.
    Curr Opin Oncol; 2011 Sep 15; 23(5):441-8. PubMed ID: 21760505
    [Abstract] [Full Text] [Related]

  • 19. Toll-like receptor stimulation in splenic marginal zone lymphoma can modulate cell signaling, activation and proliferation.
    Fonte E, Agathangelidis A, Reverberi D, Ntoufa S, Scarfò L, Ranghetti P, Cutrona G, Tedeschi A, Xochelli A, Caligaris-Cappio F, Ponzoni M, Belessi C, Davis Z, Piris MA, Oscier D, Ghia P, Stamatopoulos K, Muzio M.
    Haematologica; 2015 Nov 15; 100(11):1460-8. PubMed ID: 26294727
    [Abstract] [Full Text] [Related]

  • 20. Massive intrafollicular and arterial hyalinosis of the spleen following rituximab and methylprednisolone therapy in a patient with splenic marginal zone lymphoma.
    Schaefer IM, Marx A, Sauer C, Hohloch K, Ghadimi BM, Trümper L, Ströbel P.
    Histopathology; 2013 Mar 15; 62(4):664-7. PubMed ID: 23379885
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.